Our Quality Approach Entails:

  • Ensuring customer satisfaction by producing accurate, quality, and reliable products on time.
  • Supporting the continuous improvement of employees in order to work with qualified human resources and lay the foundations of a learning organization.
  • To comply with all legal requirements while developing the product.
  • Using the most reliable, high-quality raw materials.
  • To have production facilities that will manufacture in accordance with GMP and ISO 22000: 2018 Food Safety Management System, ISO 9001: 2015 Quality Management System and Halal Certificate standards.
  • Using the latest modern technology.
  • To control every stage, from the supply of raw materials to the delivery of the product to the end customer.
  • To make production in accordance with the nutrient contents and dosages included in the license and product label information, and having its suitability tested in an internationally recognized accredited laboratory when necessary.
  • Regularly auditing and reviewing our quality system to monitor its adequacy, appropriateness, and effectiveness.
  • To continuously improve our quality system.
482X482 | Our Quality

Production Facility

Our production facility is designed in accordance with GMP and ISO 22000: 2018 food safety standards to ensure we are consistently producing high-quality products.

In addition to the principle of one-way personnel and material flow, critical production and storage areas are monitored and recorded 24 hours a day through the automation system. GMP protocols are based on all stages of production and storage.

Our products are developed to meet international standards with an innovative approach in formulation design, raw material, and packaging materials selection at the R&D stage and are monitored and analyzed at every stage of production.

Tablet

1,250 billion pieces / year

Tablet Form

  • The ability to directly produce products in the appropriate color, size, and shape
  • Ability to produce products that are easy to drink because of their pleasant odor and taste characteristics
  • Option to produce standard and effervescent products
  • Film coating option
  • High stability against temperature, humidity, and light
  • Controlled processes ensuring product quality safety and continuity

Capsule

210 million pcs / year

Capsule Form

  • Ability to directly produce products in appropriate color, size and shape
  • High stability
  • High component stability
  • Film gelatin and vegetarian capsule usage option
  • Controlled processes ensuring product quality, safety, and continuity

Softgel

650 million pieces / year

Softgel Form

  • Ability to directly produce products in appropriate color, size and shape
  • High-quality components
  • Production flexibility to produce complex formulations
  • Increased efficiency and absorption
  • High bioavailability
  • Protection against oxidation and degradation
  • Ensuring product uniformity
  • Controlled processes ensuring product quality safety and continuity

Sachet

50 million pieces / year

Sachet Form

  • Ability to directly manufacture products with appropriate color and transparency
  • Ability to manufacture products that dissolve quickly and are easy to drink because of its pleasant odor and taste characteristics
  • High stability against temperature, humidity, and light
  • Controlled processes ensuring product quality safety and continuity

Liquid

32 million / year.

Capsule Form

For Capsules:

  • Ability to directly produce products in appropriate color, size and shape
  • High stability
  • High component stability
  • Film gelatin and vegetarian capsule usage option
  • Controlled processes ensuring product quality, safety, and continuity

Bioresearch Center

Our Bioresearch Center is a single location with a total of 915 m², including 203 m² of office space and 712 m² of laboratory space. It has been specially designed for technical personnel to carry out appropriate workspaces and research activities.

Our Bioresearch Center’s R&D strategies are based on three pillars:

  • To scientifically examine natural products that have traditional uses as old as the history of humanity, and to develop them with modern medicine. 
  • To focus on potential innovative products by identifying humanity’s future needs
  • To develop innovative raw materials through its extensive biotechnology infrastructure and knowledge base while constantly working to improve

Our R&D studies on domestic probiotic production from breast milk, which we started in 2017, continue at full speed. We are investigating the adhesion of our probiotics obtained from breast milk to the intestines and their effects on colon cancer. The scaling studies of our probiotic bacteria obtained from breast milk are carried out at the Bioresearch Center Probiotic Pilot Facility, where our 0.3-3-30 and 300L reactors are located. We have reached the final stage of scaling studies of our Lactobacillus rhamnosus NBC 14 strain in our pilot facility. We are happy to add a new member to our probiotics ready for industrial production.

Our R&D strategies:

Close